CAS 1257116-00-9

(1S,2S)-2-(1H-Benzo[D]imidazol-2-yl)-N-((R)-1-(5-(2,2,2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide

CAS : 1257116-00-9

(1S,2S)-2-(1H-Benzo[D]imidazol-2-yl)-N-((R)-1-(5-(2,2,2-trifluoroethoxy)pyrazin-2-yl)ethyl)cyclopropane-1-carboxamide is a research tool that has been shown to be an activator of the GABA receptor. It was developed as a ligand for the GABAA receptor and has been shown to have nootropic effects in animal models. This drug also binds to the alpha subunit of the GABA receptor, which is responsible for chloride ion channel opening and closing.

Formule : C₁₉H₁₈F₃N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 405.4 g/mol

Ref: 3D-HAC11600

RQ-00311651

CAS : 1257116-00-9

RQ-00311651 is a novel T-type Ca2+ channel blocker. RQ-00311651 also inhibited high K-induced Ca signaling in those cells.

Formule : C₁₉H₁₈F₃N₅O₂

Couleur et forme : Solid

Masse moléculaire : 405.37

Ref: TM-T24738